Dr. Kleinman’s research programs focus on identifying cancer driver genes in molecularly stratified patient populations; identifying molecular signatures of therapeutic resistance in cancer and understanding the functional consequences of mutations in neurodevelopmental disease genes, most specifically in pediatric brain tumors.